Healthcare & Life Sciences / Digital Therapeutics & Wellness Tech

Best Digital Therapeutics For Neurodegenerative Diseases Companies

EXECUTION STRENGTH ➡MARKET STRENGTH ➡LEADERHIGHFLIEROUTPERFORMERCHALLENGER

What is Digital Therapeutics For Neurodegenerative Diseases?

The digital therapeutics for neurodegenerative diseases market offers innovative solutions for the treatment and management of neurodegenerative diseases such as alzheimer's, parkinson's, and multiple sclerosis (MS) through technology-based interventions. These interventions can include cognitive training, physical therapy, and other forms of behavioral intervention delivered through digital platforms, mobile apps, and wearable devices. Digital therapeutics for neurodegenerative diseases offer several advantages over traditional treatment methods, such as increased patient engagement, real-time monitoring, and personalized treatment plans. They can also provide remote access to care, which is especially important for patients with mobility issues or those living in rural areas.

Expert Collections

Subscribe for more information

Market Map

Subscribe for more information

Do you compete within Digital Therapeutics For Neurodegenerative Diseases?

Reach more buyers.

Your future customers are researching their next tech solution on CB Insights. Make sure they can find you.

Top Digital Therapeutics For Neurodegenerative Diseases Companies

Neurotrack logo
Neurotrack

United States / Founded Year: 2012

Neurotrack provides digital cognitive health solutions in the healthcare technology sector. The company's offerings include cognitive screening tools for detecting cognitive impairments such as dementia and Alzheimer's, intended for use in clinical workflows. Neurotrack serves healthcare providers, payers, and research partners with its FDA-registered products that support cognitive assessments. It was founded in 2012 and is based in Redwood City, California.

Known Partners

Midi, Hannover Re, Welkin Health, and 2 more

Key People

Elli Kaplan, Stuart Zola, Aashish Mody, and 2 more

All Companies in Digital Therapeutics For Neurodegenerative Diseases

AppliedVR logo
AppliedVR

United States / Founded Year: 0000

AppliedVR develops a digital therapeutic platform. It provides virtual reality-based treatments addressing chronic pain complexities. It offers a virtual reality (VR)-based prescription therapeutic for treatment-resistant fibromyalgia and chronic intractable lower back pain. AppliedVR was founded in 2015 and is based in Van Nuys, California.

Known Partners

Subscribe, Subscribe, Subscribe, and 1 more

Key People

Subscribe, Subscribe, Subscribe, and 2 more

Brain+ logo
Brain+

Denmark / Founded Year: 0000

Brain+ provides digital dementia care solutions within the healthcare sector. The company's offering is Ayla, a Cognitive Stimulation Therapy (CST) platform intended for healthcare providers to deliver CST to patients with dementia. Ayla functions as a tool that offers guidance and activities to support dementia care. It was founded in 2012 and is based in Copenhagen, Denmark.

Known Partners

Subscribe, Subscribe, Subscribe, and 2 more

Known Customers

Subscribe, Subscribe, Subscribe, and 1 more

BrainCheck logo
BrainCheck

United States / Founded Year: 0000

BrainCheck focuses on cognitive health and operates in the healthcare technology sector. The company offers a digital platform that provides cognitive assessments, clinical decision support, and cognitive care planning. Its services are designed to help healthcare providers identify and manage dementia and cognitive impairment in their patients. It was founded in 2015 and is based in Austin, Texas.

Known Partners

Subscribe, Subscribe, Subscribe, and 1 more

Key People

Subscribe, Subscribe, Subscribe, and 2 more

Emocog logo
Emocog

South Korea / Founded Year: 0000

Emocog is a digital therapeutics company that develops software as a medical device (SaMD) for cognitive health. The company creates cognitive training regimens and diagnostic tools for individuals with mild cognitive impairment and early dementia. The products assist in the treatment and management of these cognitive conditions. It was founded in 2021 and is based in Seoul, South Korea.

Key People

Subscribe

Isaac Health logo
Isaac Health

United States / Founded Year: 0000

Isaac Health provides virtual and in-home clinical services for dementia and other brain health conditions within the healthcare sector. The company offers neuropsychological assessments, cognitive rehabilitation, medication management, and ongoing support for individuals with memory disorders and cognitive decline. Isaac Health serves the healthcare industry, partnering with health systems and payers to deliver brain health care. It was founded in 2022 and is based in New York, New York.

Known Partners

Subscribe, Subscribe, Subscribe, and 1 more

Key People

Subscribe, Subscribe

MindMaze logo
MindMaze

Switzerland / Founded Year: 0000

MindMaze provides digital neurotherapeutics services and focuses on the healthcare sector with an emphasis on brain health and recovery. The company offers a suite of medical-grade software, tailored interactive content, and proprietary peripherals designed to restore motor, cognitive, and cardiovascular functions following neural injuries, degeneration, and aging. It was founded in 2012 and is based in Lausanne, Switzerland.

Known Partners

Subscribe, Subscribe, Subscribe, and 2 more

Known Customers

Subscribe, Subscribe

Key People

Subscribe, Subscribe, Subscribe, and 2 more

Neuroglee logo
Neuroglee

Singapore / Founded Year: 0000

Neuroglee Health provides virtual cognitive care, focusing on home-based support for patients with mild cognitive impairment and dementia. The company offers services, including cognitive assessments, diagnosis, personalized care plans, and support through a digital platform. Neuroglee Health serves the healthcare sector, partnering with providers to offer cognitive care in various practice settings. It was founded in 2020 and is based in Singapore.

Known Partners

Subscribe

Key People

Subscribe, Subscribe, Subscribe

Our Methodology

The ESP matrix leverages data and analyst insight to identify and rank leading private-market companies in a given technology landscape.

What is Digital Therapeutics For Neurodegenerative Diseases?

The digital therapeutics for neurodegenerative diseases market offers innovative solutions for the treatment and management of neurodegenerative diseases such as alzheimer's, parkinson's, and multiple sclerosis (MS) through technology-based interventions. These interventions can include cognitive training, physical therapy, and other forms of behavioral intervention delivered through digital platforms, mobile apps, and wearable devices. Digital therapeutics for neurodegenerative diseases offer several advantages over traditional treatment methods, such as increased patient engagement, real-time monitoring, and personalized treatment plans. They can also provide remote access to care, which is especially important for patients with mobility issues or those living in rural areas.

Expert Collections

Subscribe for more information

Market Map

Subscribe for more information

Do you compete within Digital Therapeutics For Neurodegenerative Diseases?

Reach more buyers.

Your future customers are researching their next tech solution on CB Insights. Make sure they can find you.